Pallone on supplements
This article was originally published in The Tan Sheet
Recent statements by FDA Commissioner Mark McClellan, MD/PhD, implying a need to "crack down" on dietary supplements "create unnecessary concern among consumers and are grossly unfair to the industry as a whole," Rep. Frank Pallone (D-N.J.) states in Dec. 20 letter to agency head. Referring to McClellan's Dec. 18 announcement of FDA, FTC intentions to target misleading supplement claims, the Congressman notes such statements "give the impression that the entire industry is at fault, rather than those few manufacturers that are not in compliance" (1"The Tan Sheet" Dec. 23, 2002, p. 11). Pallone criticizes FDA's "ineffective and inefficient" attempts to implement DSHEA, requests meeting "to discuss federal legislation regarding" supplements and Congress' expectations for agency...
You may also be interested in...
Dietary supplements marketed to smokers and drinkers are two of nine categories of products that "warrant close scrutiny" for enforcement, FDA says
AstraZeneca has sent a legal notice to Indian partner Serum Institute for non-delivery of COVID-19 vaccines. Will this and the entry of a new challenger, Sputnik V, in the Indian market affect Serum’s fortunes? Will the EMA and MHRA announcement on clotting incidents related to the AZ vaccine shrink demand for the partnered vaccine?
As medical organizations such as the Veterans Health Administration and Mayo Clinic are positioning themselves to become medical device manufacturers using 3D printing technologies, it opens challenges and opportunities. See what Mayo Clinic’s Sean McEligot said about it here.